The observed safety findings and overall tolerability in patients with T2DM are consistent with those in previously reported studies in patients with cryopyrin-associated periodic syndrome, gouty arthritis and systemic juvenile idiopathic arthritis[21-23]. The gene discussed is NLRP3; the disease is type 2 diabetes mellitus.